An event-related potential study of the effects of acupuncture intervention on cognitive functioning in partial sleep deprivation in generalized anxiety co-morbidity

The clinical efficacy and neurophysiological mechanisms of acupuncture for generalized anxiety co-morbidities naturally occurring partial sleep deprivation

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400082221

Enrollment

Unknown

Registered

2024-03-25

Start date

2024-03-25

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generalized anxiety co-morbid partial sleep deprivation

Interventions

test group:Acupuncture on Baihui, Yintang, Hegu, Taichong, Neiguan, Sanyinjiao Treatment

control group:Use of sham acupuncture Baihui, Yintang, Hegu, Taichong, Neiguan, and Sanyinjiao without allowing the tip of the acupuncture the skin and without exposing the subject to therapeutic effe

Eligibility

Sex/Gender

All

Age

18 Years to 25 Years

Inclusion criteria

Inclusion criteria: (1) Aged between 18 and 25 years; (2) The above diagnostic criteria were accompanied by an average nightly sleep duration of =6h for more than 30d; (3) A score of =5 on the 7-item Generalized Anxiety Disorder Scale (GDA-7); (4) Not having taken any anti-anxiety or insomnia medication or received any anti-anxiety or insomnia acupuncture treatment within the past 30 days; (5) Those who volunteered to participate in the clinical study and agreed to sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Organic mental disorders, or anxiety or depression associated with a history of surgery or psychoactive substances; (2) Family history of other psychiatric disorders such as dementia, schizophrenia, mania, addiction; (3) Those with conscious cognitive impairment who are unable to cooperate; (4) Having pregnancy, preparing for pregnancy or breastfeeding; (5) Those with comorbidities such as skin lesions or patients with skin diseases, severe diabetes, tumors, or severe cardiovascular, pulmonary, hepatic, renal, and hematopoietic system and other medical diseases.

Design outcomes

Primary

Measure	Time frame
Hamilton Anxiety Scale(HAMA);	—

Secondary

Measure	Time frame
sleep deprivation index (SDI);The Epworth Sleeping Scale(ESS);State-Trait Anxiety Inventory(STAI);Self-Rating Anxiety Scale(SAS);P300, N100, N200, P200 amplitude and latency;	—

Countries

China

Contacts

Public ContactShi Ce

Third Affiliated Hospital of Henan University of traditional Chinese Medicine

574186442@qq.com+86 176 3815 3236

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026